+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sympathetic nervous system, diabetes, and hypertension



Sympathetic nervous system, diabetes, and hypertension



Clinical & Experimental Hypertension 23(1-2): 45-55, January-February



Hypertension is twice as frequent in diabetic patients than in the general population. Its prevalence is higher in Type 2 than in Type 1 diabetes: in the former, the onset of hypertension often precedes the diagnosis of diabetes, whereas, in the latter it is strictly related to the presence of nephropathy. Sympathetic nerve overactivity is crucial in the pathogenesis of hypertension in diabetes. It can be related to the activation of the renin-angiotensin-aldosterone (RAA) system in Type 1 diabetic patients with chronic renal failure, or to a condition of insulin resistance/hyperinsulinemia in Type 2 patients with the metabolic syndrome. In patients with early autonomic neuropathy, vagal impairment can lead to a relative predominance of sympathetic activity in the sympatho-vagal balance. In these patients, the onset of hypertension is frequently preceded by reduced nocturnal dipping. Sympathetic overactivity stimulates RAA activity, promotes sodium reabsorption, and increases heart rate, stroke volume and peripheral vascular resistance, thus inducing hypertension and increasing cardiovascular risk. A number of drugs acting either directly or indirectly on sympathetic activity are available for the treatment of hypertension in diabetic subjects. Opinions on the potential advantages of the metabolic profile of some of these drugs are as yet conflicting.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011435522

Download citation: RISBibTeXText

PMID: 11270588

DOI: 10.1081/ceh-100001196


Related references

Bispidines for radiopharmaceuticals. Dalton Transactions 47(28): 9202-9220, 2018

The contribution of the sympathetic nervous system to hypertension in diabetes mellitus. Diabete and Metabolisme 15(5 Pt 2): 313-317, 1989

Role of sympathetic nervous system in experimental hypertension and diabetes mellitus. Clinical & Experimental Hypertension 21(1-2): 95-112, 1999

Bis(perchlorocatecholato)silane-A Neutral Silicon Lewis Super Acid. Angewandte Chemie 57(6): 1717-1720, 2018

Bisphosphonates reduce the risk of knee replacement: we need more analyses!. Annals of the Rheumatic Diseases 78(2): E15, 2019

Bisphosphonates therapy in children with Osteogenesis imperfecta: clinical experience in oral surgery. Oral and Implantology 10(3): 311-316, 2017

Bisphosphonate use after clinical fracture and risk of new fracture. Osteoporosis International 29(4): 937-945, 2018

Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients. Cancer Epidemiology Biomarkers and Prevention 27(2): 165-173, 2018

Bisphosphonate Use in Pediatric Oncology for Pain Management. American Journal of Hospice and Palliative Care 36(2): 138-142, 2019

Bisphosphonates prevent age-related weight loss in Japanese postmenopausal women. Journal of Bone and Mineral Metabolism 36(6): 734-740, 2018

Role of the parasympathetic nervous system and interaction with the sympathetic nervous system in the early phase of hypertension. Journal of Cardiovascular Pharmacology 36(Suppl. 2): S61-S64, 2000

Role of central nervous system and sympathetic nervous system in essential hypertension. Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl. 1): 285-291, 2000

Nitric oxide expression in the sympathetic nervous system in diabetes and sympathetic nerve injury. Society for Neuroscience Abstracts 26(1-2): Abstract No -537 4, 2000

Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease. High Blood Pressure and Cardiovascular Prevention 21(2): 89, 2014

Medical management of hypertension; role of the sympathetic nervous system in hypertension and pharmacology of drug therapy. Texas State Journal of Medicine 51(10): 693-696, 1955